These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29019032)

  • 1. Nanotechnology as a Delivery Tool for Precision Cancer Therapies.
    Sharma B; Crist RM; Adiseshaiah PP
    AAPS J; 2017 Nov; 19(6):1632-1642. PubMed ID: 29019032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-based strategies to target and modulate the tumor microenvironment.
    Mendes BB; Sousa DP; Conniot J; Conde J
    Trends Cancer; 2021 Sep; 7(9):847-862. PubMed ID: 34090865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation.
    Gu W; Meng F; Haag R; Zhong Z
    J Control Release; 2021 Jan; 329():676-695. PubMed ID: 33022328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-decorated polymeric nanomedicines for precision cancer therapy.
    Sun H; Dong Y; Feijen J; Zhong Z
    J Control Release; 2018 Nov; 290():11-27. PubMed ID: 30290243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface.
    Tracey SR; Smyth P; Barelle CJ; Scott CJ
    Biochem Soc Trans; 2021 Nov; 49(5):2253-2269. PubMed ID: 34709394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
    Gupta A; Ahmad A; Dar AI; Khan R
    Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.
    Balasubramanian V; Liu Z; Hirvonen J; Santos HA
    Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28570787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking Down the Barriers to Precision Cancer Nanomedicine.
    von Roemeling C; Jiang W; Chan CK; Weissman IL; Kim BYS
    Trends Biotechnol; 2017 Feb; 35(2):159-171. PubMed ID: 27492049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical clinical gaps in cancer precision nanomedicine development.
    Gan WW; Chan LW; Li W; Wong TW
    J Control Release; 2022 May; 345():811-818. PubMed ID: 35378214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
    Wicki A; Witzigmann D; Balasubramanian V; Huwyler J
    J Control Release; 2015 Feb; 200():138-57. PubMed ID: 25545217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.